pharmacokinetic study of Livalo complex product in healthy male subjects
Not Applicable
Completed
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0000161
- Lead Sponsor
- JW Pharmaceutical
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Healthy male volunteers
Age 20-55 years at the time of Screening
BMI 19-26 kg/m2 at the time of Screening
Exclusion Criteria
Received other investigational drug within 90 days prior to the first dose of study drug
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method